Last 12 months
Inside the activity.
1 purchase rows · 32 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 8 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 14 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 11, 2020 Filed May 12, 2020 00:36 UTC |
Hessekiel JeffreyEVP and General Counsel
|
Exercise / conversionCommon Stock | 38,006 | $1.90 | $72,211.40 |
DisclosureSEC source: 0000939767-20-000077 · wf-form4_158924379144708.xml · nonDerivative · entry 5 Hessekiel Jeffrey · CIK 0001599803 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,194 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2020 Filed May 14, 2020 01:16 UTC |
MARCHESI VINCENT TDirector
|
Exercise / conversionOption (right to buy) · Derivative | 30,000 | $0.00 Strike: $4.58 | $0.00 |
DisclosureSEC source: 0000939767-20-000080 · wf-form4_158941895308188.xml · derivative · entry 3 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2020-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing the right to purchase a total of 30,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 23, 2013. Read SEC document |
| May 11, 2020 Filed May 14, 2020 01:16 UTC |
MARCHESI VINCENT TDirector
|
SaleCommon Stock | 30,000 | $26.30 | $789,000.00 |
DisclosureSEC source: 0000939767-20-000080 · wf-form4_158941895308188.xml · nonDerivative · entry 2 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,484 F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $26.00 to $26.70. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Read SEC document |
| May 11, 2020 Filed May 14, 2020 01:16 UTC |
MARCHESI VINCENT TDirector
|
Exercise / conversionCommon Stock | 30,000 | $4.58 | $137,400.00 |
DisclosureSEC source: 0000939767-20-000080 · wf-form4_158941895308188.xml · nonDerivative · entry 1 MARCHESI VINCENT T · CIK 0001202095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,484 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 10,317 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| May 08, 2020 Filed May 9, 2020 01:10 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
GiftCommon Stock | 126,313 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-20-000069 · wf-form4_158898659618826.xml · nonDerivative · entry 4 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 853,639 F3 · kind: On May 8, 2020, the Reporting Person gifted 126,313 shares to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended. F4 · ownership.nature: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Read SEC document |
| May 08, 2020 Filed May 9, 2020 01:10 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
GiftCommon Stock | 126,313 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-20-000069 · wf-form4_158898659618826.xml · nonDerivative · entry 3 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,985 F3 · kind: On May 8, 2020, the Reporting Person gifted 126,313 shares to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended. Read SEC document |
| May 08, 2020 Filed May 9, 2020 01:22 UTC |
Senner Christopher J.EVP and CFO
|
Exercise / conversionOption (right to buy) · Derivative | 78,583 | $0.00 Strike: $3.66 | $0.00 |
DisclosureSEC source: 0000939767-20-000075 · wf-form4_158898730774345.xml · derivative · entry 7 Senner Christopher J. · CIK 0001648367 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 78,583 shares Expires 2022-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option, representing the right to purchase a total of 350,000 shares of Exelixis, Inc. common stock, became fully exercisable on July 15, 2019. Read SEC document |
| May 08, 2020 Filed May 9, 2020 01:22 UTC |
Senner Christopher J.EVP and CFO
|
SaleCommon Stock | 78,583 | $25.81 | $2,028,227.23 |
DisclosureSEC source: 0000939767-20-000075 · wf-form4_158898730774345.xml · nonDerivative · entry 4 Senner Christopher J. · CIK 0001648367 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,703 F3 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $25.51 to $25.97. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Read SEC document |
| May 08, 2020 Filed May 9, 2020 01:22 UTC |
Senner Christopher J.EVP and CFO
|
Exercise / conversionCommon Stock | 78,583 | $3.66 | $287,613.78 |
DisclosureSEC source: 0000939767-20-000075 · wf-form4_158898730774345.xml · nonDerivative · entry 3 Senner Christopher J. · CIK 0001648367 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 08, 2020 Filed May 9, 2020 01:18 UTC |
PAPADOPOULOS STELIOSDirector
|
Exercise / conversionOption (right to buy) · Derivative | 15,000 | $0.00 Strike: $5.92 | $0.00 |
DisclosureSEC source: 0000939767-20-000074 · wf-form4_158898709740775.xml · derivative · entry 5 PAPADOPOULOS STELIOS · CIK 0001202098 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2020-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 19, 2010. Read SEC document |
| May 08, 2020 Filed May 9, 2020 01:18 UTC |
PAPADOPOULOS STELIOSDirector
|
Exercise / conversionOption (right to buy) · Derivative | 30,000 | $0.00 Strike: $4.58 | $0.00 |
DisclosureSEC source: 0000939767-20-000074 · wf-form4_158898709740775.xml · derivative · entry 4 PAPADOPOULOS STELIOS · CIK 0001202098 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2020-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing the right to purchase a total of 30,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 23, 2013. Read SEC document |
| May 08, 2020 Filed May 9, 2020 01:18 UTC |
PAPADOPOULOS STELIOSDirector
|
SaleCommon Stock | 45,000 | $25.84 | $1,162,800.00 |
DisclosureSEC source: 0000939767-20-000074 · wf-form4_158898709740775.xml · nonDerivative · entry 3 PAPADOPOULOS STELIOS · CIK 0001202098 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,052,568 F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $25.78 to $25.93. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Read SEC document |
| May 08, 2020 Filed May 9, 2020 01:18 UTC |
PAPADOPOULOS STELIOSDirector
|
Exercise / conversionCommon Stock | 15,000 | $5.92 | $88,800.00 |
DisclosureSEC source: 0000939767-20-000074 · wf-form4_158898709740775.xml · nonDerivative · entry 2 PAPADOPOULOS STELIOS · CIK 0001202098 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,097,568 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 08, 2020 Filed May 9, 2020 01:18 UTC |
PAPADOPOULOS STELIOSDirector
|
Exercise / conversionCommon Stock | 30,000 | $4.58 | $137,400.00 |
DisclosureSEC source: 0000939767-20-000074 · wf-form4_158898709740775.xml · nonDerivative · entry 1 PAPADOPOULOS STELIOS · CIK 0001202098 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,082,568 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 10,317 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| May 08, 2020 Filed May 9, 2020 01:16 UTC |
Haley Patrick J.EVP, Commercial
|
Exercise / conversionOption (right to buy) · Derivative | 21,375 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0000939767-20-000073 · wf-form4_158898695727374.xml · derivative · entry 5 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,375 shares Expires 2021-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option, representing the right to purchase a total of 50,000 shares of Exelixis, Inc. common stock, became fully exercisable on November 17, 2018 Read SEC document |
| May 08, 2020 Filed May 9, 2020 01:16 UTC |
Haley Patrick J.EVP, Commercial
|
SaleCommon Stock | 21,375 | $25.87 | $552,971.25 |
DisclosureSEC source: 0000939767-20-000073 · wf-form4_158898695727374.xml · nonDerivative · entry 2 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,491 F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $25.79 to $25.88. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Read SEC document |
| May 08, 2020 Filed May 9, 2020 01:16 UTC |
Haley Patrick J.EVP, Commercial
|
Exercise / conversionCommon Stock | 21,375 | $1.76 | $37,620.00 |
DisclosureSEC source: 0000939767-20-000073 · wf-form4_158898695727374.xml · nonDerivative · entry 1 Haley Patrick J. · CIK 0001692954 · EVP, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,866 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 72,614 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 1,618 shares of common stock acquired on April 30, 2020, pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan. Read SEC document |
| May 08, 2020 Filed May 12, 2020 00:36 UTC |
Hessekiel JeffreyEVP and General Counsel
|
Exercise / conversionOption (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.90 | $0.00 |
DisclosureSEC source: 0000939767-20-000077 · wf-form4_158924379144708.xml · derivative · entry 9 Hessekiel Jeffrey · CIK 0001599803 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,698 Underlying: Common Stock · 25,000 shares Expires 2022-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option, representing the right to purchase a total of 200,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016. Read SEC document |
| May 08, 2020 Filed May 12, 2020 00:36 UTC |
Hessekiel JeffreyEVP and General Counsel
|
SaleCommon Stock | 25,000 | $26.04 | $651,000.00 |
DisclosureSEC source: 0000939767-20-000077 · wf-form4_158924379144708.xml · nonDerivative · entry 4 Hessekiel Jeffrey · CIK 0001599803 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,188 F3 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $26.00 to $26.14. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Read SEC document |
| May 08, 2020 Filed May 12, 2020 00:36 UTC |
Hessekiel JeffreyEVP and General Counsel
|
Exercise / conversionCommon Stock | 25,000 | $1.90 | $47,500.00 |
DisclosureSEC source: 0000939767-20-000077 · wf-form4_158924379144708.xml · nonDerivative · entry 3 Hessekiel Jeffrey · CIK 0001599803 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,188 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2020 Filed May 9, 2020 01:22 UTC |
Senner Christopher J.EVP and CFO
|
Exercise / conversionOption (right to buy) · Derivative | 21,417 | $0.00 Strike: $3.66 | $0.00 |
DisclosureSEC source: 0000939767-20-000075 · wf-form4_158898730774345.xml · derivative · entry 6 Senner Christopher J. · CIK 0001648367 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,583 Underlying: Common Stock · 21,417 shares Expires 2022-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option, representing the right to purchase a total of 350,000 shares of Exelixis, Inc. common stock, became fully exercisable on July 15, 2019. Read SEC document |
| May 07, 2020 Filed May 9, 2020 01:22 UTC |
Senner Christopher J.EVP and CFO
|
SaleCommon Stock | 21,417 | $25.80 | $552,558.60 |
DisclosureSEC source: 0000939767-20-000075 · wf-form4_158898730774345.xml · nonDerivative · entry 2 Senner Christopher J. · CIK 0001648367 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,703 F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $25.75 to $25.99. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Read SEC document |
| May 07, 2020 Filed May 9, 2020 01:22 UTC |
Senner Christopher J.EVP and CFO
|
Exercise / conversionCommon Stock | 21,417 | $3.66 | $78,386.22 |
DisclosureSEC source: 0000939767-20-000075 · wf-form4_158898730774345.xml · nonDerivative · entry 1 Senner Christopher J. · CIK 0001648367 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,120 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 49,244 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| May 07, 2020 Filed May 9, 2020 01:14 UTC |
FELDBAUM CARL BDirector
|
Exercise / conversionOption (right to buy) · Derivative | 20,000 | $0.00 Strike: $3.38 | $0.00 |
DisclosureSEC source: 0000939767-20-000072 · wf-form4_158898685314353.xml · derivative · entry 5 FELDBAUM CARL B · CIK 0001326377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2021-05-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing the right to purchase a total of 40,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 29, 2014. Read SEC document |
| May 07, 2020 Filed May 9, 2020 01:14 UTC |
FELDBAUM CARL BDirector
|
Exercise / conversionOption (right to buy) · Derivative | 11,546 | $0.00 Strike: $5.82 | $0.00 |
DisclosureSEC source: 0000939767-20-000072 · wf-form4_158898685314353.xml · derivative · entry 4 FELDBAUM CARL B · CIK 0001326377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,546 shares Expires 2020-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option, representing the right to purchase a total of 43,546 shares of Exelixis, Inc. common stock, became fully exercisable on December 6, 2013. Read SEC document |
| May 07, 2020 Filed May 9, 2020 01:14 UTC |
FELDBAUM CARL BDirector
|
SaleCommon Stock | 31,546 | $25.02 | $789,280.92 |
DisclosureSEC source: 0000939767-20-000072 · wf-form4_158898685314353.xml · nonDerivative · entry 3 FELDBAUM CARL B · CIK 0001326377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,521 Read SEC document |
| May 07, 2020 Filed May 9, 2020 01:14 UTC |
FELDBAUM CARL BDirector
|
Exercise / conversionCommon Stock | 20,000 | $3.38 | $67,600.00 |
DisclosureSEC source: 0000939767-20-000072 · wf-form4_158898685314353.xml · nonDerivative · entry 2 FELDBAUM CARL B · CIK 0001326377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,067 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2020 Filed May 9, 2020 01:14 UTC |
FELDBAUM CARL BDirector
|
Exercise / conversionCommon Stock | 11,546 | $5.82 | $67,197.72 |
DisclosureSEC source: 0000939767-20-000072 · wf-form4_158898685314353.xml · nonDerivative · entry 1 FELDBAUM CARL B · CIK 0001326377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,067 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2020 Filed May 9, 2020 01:13 UTC |
POSTE GEORGEDirector
|
Exercise / conversionOption (right to buy) · Derivative | 30,000 | $0.00 Strike: $5.82 | $0.00 |
DisclosureSEC source: 0000939767-20-000071 · wf-form4_158898677213589.xml · derivative · entry 3 POSTE GEORGE · CIK 0001180770 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,662 Underlying: Common Stock · 30,000 shares Expires 2020-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing the right to purchase a total of 59,662 shares of Exelixis, Inc. common stock, became fully exercisable on December 6, 2013. Read SEC document |
| May 07, 2020 Filed May 9, 2020 01:13 UTC |
POSTE GEORGEDirector
|
SaleCommon Stock | 30,000 | $25.61 | $768,300.00 |
DisclosureSEC source: 0000939767-20-000071 · wf-form4_158898677213589.xml · nonDerivative · entry 2 POSTE GEORGE · CIK 0001180770 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,792 F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $25.50 to $25.85. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Read SEC document |
| May 07, 2020 Filed May 9, 2020 01:13 UTC |
POSTE GEORGEDirector
|
Exercise / conversionCommon Stock | 30,000 | $5.82 | $174,600.00 |
DisclosureSEC source: 0000939767-20-000071 · wf-form4_158898677213589.xml · nonDerivative · entry 1 POSTE GEORGE · CIK 0001180770 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,792 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 10,317 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| May 07, 2020 Filed May 9, 2020 01:11 UTC |
Lamb PeterEVP, Scientific Strategy & CSO
|
Exercise / conversionOption (right to buy) · Derivative | 50,000 | $0.00 Strike: $5.51 | $0.00 |
DisclosureSEC source: 0000939767-20-000070 · wf-form4_158898668578327.xml · derivative · entry 4 Lamb Peter · CIK 0001387306 · EVP, Scientific Strategy & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 Underlying: Common Stock · 50,000 shares Expires 2020-09-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option, representing the right to purchase a total of 126,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 18, 2017. Read SEC document |
| May 07, 2020 Filed May 9, 2020 01:11 UTC |
Lamb PeterEVP, Scientific Strategy & CSO
|
SaleCommon Stock | 50,000 | $25.54 | $1,277,000.00 |
DisclosureSEC source: 0000939767-20-000070 · wf-form4_158898668578327.xml · nonDerivative · entry 2 Lamb Peter · CIK 0001387306 · EVP, Scientific Strategy & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,531 F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2020. F3 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $25.28 to $25.91. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Read SEC document |
| May 07, 2020 Filed May 9, 2020 01:11 UTC |
Lamb PeterEVP, Scientific Strategy & CSO
|
Exercise / conversionCommon Stock | 50,000 | $5.51 | $275,500.00 |
DisclosureSEC source: 0000939767-20-000070 · wf-form4_158898668578327.xml · nonDerivative · entry 1 Lamb Peter · CIK 0001387306 · EVP, Scientific Strategy & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 44,057 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| May 07, 2020 Filed May 12, 2020 00:36 UTC |
Hessekiel JeffreyEVP and General Counsel
|
Exercise / conversionOption (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.90 | $0.00 |
DisclosureSEC source: 0000939767-20-000077 · wf-form4_158924379144708.xml · derivative · entry 8 Hessekiel Jeffrey · CIK 0001599803 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,698 Underlying: Common Stock · 30,000 shares Expires 2022-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option, representing the right to purchase a total of 200,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016. Read SEC document |
| May 07, 2020 Filed May 12, 2020 00:36 UTC |
Hessekiel JeffreyEVP and General Counsel
|
SaleCommon Stock | 30,000 | $25.61 | $768,300.00 |
DisclosureSEC source: 0000939767-20-000077 · wf-form4_158924379144708.xml · nonDerivative · entry 2 Hessekiel Jeffrey · CIK 0001599803 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,188 F2 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $25.60 to $25.66. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4. Read SEC document |
| May 07, 2020 Filed May 12, 2020 00:36 UTC |
Hessekiel JeffreyEVP and General Counsel
|
Exercise / conversionCommon Stock | 30,000 | $1.90 | $57,000.00 |
DisclosureSEC source: 0000939767-20-000077 · wf-form4_158924379144708.xml · nonDerivative · entry 1 Hessekiel Jeffrey · CIK 0001599803 · EVP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,188 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 36,559 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 1,618 shares of common stock acquired on April 30, 2020, pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan. Read SEC document |
| May 06, 2020 Filed May 9, 2020 01:10 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
Exercise / conversionOption (right to buy) · Derivative | 285,284 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0000939767-20-000069 · wf-form4_158898659618826.xml · derivative · entry 6 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 285,284 shares Expires 2021-09-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option, representing the right to purchase a total of 1,125,000 shares of Common Stock, became fully exercisable on April 28, 2016. Read SEC document |
| May 06, 2020 Filed May 9, 2020 01:10 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
Tax withholdingCommon Stock | 158,971 | $26.19 | $4,163,450.49 |
DisclosureSEC source: 0000939767-20-000069 · wf-form4_158898659618826.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,298 F2 · kind: Represents a "net exercise" of an outstanding stock option. The Reporting Person received 126,313 shares of Common Stock on the net exercise of a stock option to purchase 285,284 shares of Common Stock. The Issuer withheld 158,971 shares of Common Stock underlying the stock option for payment of the exercise price and tax withholding using a stock price on May 6, 2020 of $26.19. Read SEC document |
| May 06, 2020 Filed May 9, 2020 01:10 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
Exercise / conversionCommon Stock | 285,284 | $1.70 | $484,982.80 |
DisclosureSEC source: 0000939767-20-000069 · wf-form4_158898659618826.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 371,269 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 85,985 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| April 29, 2020 Filed Apr 30, 2020 00:10 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
GiftCommon Stock | 126,565 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-20-000059 · wf-form4_158820542239461.xml · nonDerivative · entry 6 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 727,326 F5 · kind: On April 29, 2020, the Reporting Person gifted 126,565 shares to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended. Read SEC document |
| April 29, 2020 Filed Apr 30, 2020 00:10 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
GiftCommon Stock | 126,565 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-20-000059 · wf-form4_158820542239461.xml · nonDerivative · entry 5 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,985 F5 · kind: On April 29, 2020, the Reporting Person gifted 126,565 shares to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended. Read SEC document |
| April 27, 2020 Filed Apr 30, 2020 00:10 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
Exercise / conversionOption (right to buy) · Derivative | 285,000 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0000939767-20-000059 · wf-form4_158820542239461.xml · derivative · entry 8 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,284 Underlying: Common Stock · 285,000 shares Expires 2021-09-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option, representing the right to purchase a total of 1,125,000 shares of Common Stock, became fully exercisable on April 28, 2016. Read SEC document |
| April 27, 2020 Filed Apr 30, 2020 00:10 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
Tax withholdingCommon Stock | 158,435 | $27.37 | $4,336,365.95 |
DisclosureSEC source: 0000939767-20-000059 · wf-form4_158820542239461.xml · nonDerivative · entry 4 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,550 F4 · kind: Represents a "net exercise" of an outstanding stock option. The Reporting Person received 126,565 shares of Common Stock on the net exercise of a stock option to purchase 285,000 shares of Common Stock. The Issuer withheld 158,435 shares of Common Stock underlying the stock option for payment of the exercise price and tax withholding using a stock price on April 27, 2020 of $27.37. Read SEC document |
| April 27, 2020 Filed Apr 30, 2020 00:10 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
Exercise / conversionCommon Stock | 285,000 | $1.70 | $484,500.00 |
DisclosureSEC source: 0000939767-20-000059 · wf-form4_158820542239461.xml · nonDerivative · entry 3 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 370,985 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 27, 2020 Filed Apr 30, 2020 00:10 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
GiftCommon Stock | 93,640 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-20-000059 · wf-form4_158820542239461.xml · nonDerivative · entry 2 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 600,761 F1 · kind: On April 27, 2020, the Reporting Person gifted 93,640 shares to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended. F3 · ownership.nature: Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended. Read SEC document |
| April 27, 2020 Filed Apr 30, 2020 00:10 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
GiftCommon Stock | 93,640 | $0.00 | $0.00 |
DisclosureSEC source: 0000939767-20-000059 · wf-form4_158820542239461.xml · nonDerivative · entry 1 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,985 F1 · kind: On April 27, 2020, the Reporting Person gifted 93,640 shares to Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Trust dated July 21, 1994, as amended. F2 · balance_after: Includes 85,985 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units. Read SEC document |
| April 24, 2020 Filed Apr 25, 2020 00:24 UTC |
SCANGOS GEORGE ADirector
|
SaleCommon Stock | 15,000 | $26.24 | $393,600.00 |
DisclosureSEC source: 0000939767-20-000056 · wf-form4_158777422299168.xml · nonDerivative · entry 3 SCANGOS GEORGE A · CIK 0001202102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 738,031 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2019. F4 · price: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $25.86 to $26.66. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4. Read SEC document |
| April 23, 2020 Filed Apr 25, 2020 00:41 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
Exercise / conversionOption (right to buy) · Derivative | 250,000 | $0.00 Strike: $5.51 | $0.00 |
DisclosureSEC source: 0000939767-20-000058 · wf-form4_158777524774901.xml · derivative · entry 6 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250,000 shares Expires 2020-09-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option, representing the right to purchase a total of 720,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 18, 2017. Read SEC document |
| April 23, 2020 Filed Apr 25, 2020 00:41 UTC |
MORRISSEY MICHAELDirector · President and CEO
|
Tax withholdingCommon Stock | 156,360 | $26.37 | $4,123,213.20 |
DisclosureSEC source: 0000939767-20-000058 · wf-form4_158777524774901.xml · nonDerivative · entry 4 MORRISSEY MICHAEL · CIK 0001202096 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,625 F4 · kind: Represents a "net exercise" of an outstanding stock option. The Reporting Person received 93,640 shares of Common Stock on the net exercise of a stock option to purchase 250,000 shares of Common Stock. The Issuer withheld 156,360 shares of Common Stock underlying the stock option for payment of the exercise price and tax withholding using a stock price on April 23, 2020 of $26.37. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.